1. Alexander, M., Upadhyay, V., Rock, R., Ramirez, L., Puchalska, P., Orellana, D., Ang, Q.Y., Turnbaugh, J.A., Tian Y., Dumlao, D., Nayak, R.R., Patterson, A., Newman, J.C, Crawford, P.A, Turnbaugh, P.J. 2023. A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity. BioRxiv (preprint).
  2. Alexander, M., Ang, Q.Y., Nayak, R.R., Bustion, A.E., Sandy, M., Zhang, B., Upadhyay, V., Pollard, K.S., Lynch, S.V., and Turnbaugh, P.J. 2022. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host & Microbe. 30, 17 – 30.e9.
  3. Ang, Q.Y., Alexander, M., Newman, J.C., Tian, Y., Cai, J., Upadhyay, V., Turnbaugh, J.A., Verdin, E., Hall, K.D., Leibel, L.L., Ravussin, E., Rosenbaum, M., Patterson, A.D., and Turnbaugh, P.J. 2020. Ketogenesis alters the gut microbiome resulting in decreased intestinal Th17 levels. Cell 181, 1263-1275.E16.
  4. Alexander, M. and Turnbaugh, P.J. 2020. Deconstructing mechanisms of diet-microbiome-immune interactions. Immunity 53, 264-276.
  5. Nayak, R.R., Alexander, M., Deshpande, I., Stapleton-Gray, K., Rimal, B., Patterson, A.D., Ubeda, C., Scher, J.U., and Turnbaugh, P.J. 2021. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host & Microbe 29, 362-377.e11.
  6. Lam, K.N.*, Alexander, M.*, and Turnbaugh, P.J. 2019. Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host & Microbe 26, 22-34.

For a full list of publications see:

Publications List